Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus dexmedetomidine versus midazolam for sedation during ultrasound-guided nerve block
ChiCTR2000035388Phase 4Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Procedural anxiety (3 arms), sponsored by Anhui Provincial Tumor Hospital. Primary endpoints: Hemodynamic index, SpO2 and 2 more. Started Aug 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Procedural anxiety
Beyond the preview
Go deeper on ChiCTR2000035388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035388.